659 related articles for article (PubMed ID: 25751127)
21. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients.
Xia Z; Yang R; Wang W; Cong L
Mycopathologia; 2012 Mar; 173(2-3):127-33. PubMed ID: 21979867
[TBL] [Abstract][Full Text] [Related]
22. In Vitro Activity of Berberine Alone and in Combination with Antifungal Drugs Against Planktonic Forms and Biofilms of Trichosporon Asahii.
Cong L; Liao Y; Yang S; Yang R
Mycopathologia; 2017 Oct; 182(9-10):829-837. PubMed ID: 28144822
[TBL] [Abstract][Full Text] [Related]
23. Biofilm formation and antifungal susceptibility of Trichosporon asahii isolates from Mexican patients.
Montoya AM; Elizondo-Zertuche M; Treviño-Rangel RJ; Becerril-García M; González GM
Rev Iberoam Micol; 2018; 35(1):22-26. PubMed ID: 29287630
[TBL] [Abstract][Full Text] [Related]
24. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen.
Dabas Y; Xess I; Kale P
Med Mycol; 2017 Jul; 55(5):518-527. PubMed ID: 27816903
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic efficacy of posaconazole in a murine model of disseminated trichosporonosis.
Treviño-Rangel Rde J; López LJ; Palma-Nicolás JP; Hernández-Bello R; González JG; González GM
J Antimicrob Chemother; 2014 Apr; 69(4):1075-8. PubMed ID: 24252752
[TBL] [Abstract][Full Text] [Related]
26. Trichosporon inkin as an Emergent Pathogen in Patients With Severe Pemphigus.
Nobrega de Almeida Júnior J; Buccheri de Oliveira R; Duarte A; Lopes Motta A; Rossi F; Sachiko Yamamoto de Figueiredo D; Barbaro Del Negro GM; Aoki V; Wakisaka Maruta C; Giuli Santi C; Benard G
JAMA Dermatol; 2015 Jun; 151(6):642-5. PubMed ID: 25785367
[TBL] [Abstract][Full Text] [Related]
27. In vitro interaction of itraconazole with amphotericin B, caspofungin, and terbinafine against clinical isolates of Trichosporon asahii.
Li H; Qiao J; Wan Z; Zhang J
Mycopathologia; 2011 May; 171(5):345-8. PubMed ID: 21153882
[TBL] [Abstract][Full Text] [Related]
28. A novel silkworm infection model with fluorescence imaging using transgenic Trichosporon asahii expressing eGFP.
Matsumoto Y; Yamazaki H; Yamasaki Y; Tateyama Y; Yamada T; Sugita T
Sci Rep; 2020 Jul; 10(1):10991. PubMed ID: 32620930
[TBL] [Abstract][Full Text] [Related]
29. Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients.
Montoya AM; Sánchez González A; Palma-Nicolás JP; Gómez-Treviño A; González JG; González GM
Med Mycol; 2015 Jun; 53(5):505-11. PubMed ID: 25980003
[TBL] [Abstract][Full Text] [Related]
30. Trichosporon inkin meningitis in Northeast Brazil: first case report and review of the literature.
Milan EP; Silva-Rocha WP; de Almeida JJS; Fernandes TUG; de Araújo Prudente AL; de Azevedo MF; Francisco EC; de Azevedo Melo AS; Colombo AL; Chaves GM
BMC Infect Dis; 2018 Sep; 18(1):470. PubMed ID: 30227852
[TBL] [Abstract][Full Text] [Related]
31. Invasive Infections Due to
Guo LN; Yu SY; Hsueh PR; Al-Hatmi AMS; Meis JF; Hagen F; Xiao M; Wang H; Barresi C; Zhou ML; de Hoog GS; Xu YC
J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30463892
[TBL] [Abstract][Full Text] [Related]
32. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
Pfaller MA; Castanheira M; Messer SA; Jones RN
Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
[TBL] [Abstract][Full Text] [Related]
33. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance.
Di Bonaventura G; Pompilio A; Picciani C; Iezzi M; D'Antonio D; Piccolomini R
Antimicrob Agents Chemother; 2006 Oct; 50(10):3269-76. PubMed ID: 17005804
[TBL] [Abstract][Full Text] [Related]
34. Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis.
Yang RY; Wang WL; Ao JH; Hao ZF; Zhang J; Wang CM
Chin Med J (Engl); 2008 Dec; 121(24):2557-60. PubMed ID: 19187595
[TBL] [Abstract][Full Text] [Related]
35. Comparison of NCCLS microdilution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolates.
Arikan S; Hasçelik G
Diagn Microbiol Infect Dis; 2002 Jun; 43(2):107-11. PubMed ID: 12088616
[TBL] [Abstract][Full Text] [Related]
36. Trichosporon asahii infection presenting as chronic meningo-ventriculitis and intra ventricular fungal ball: a case report and literature review.
Kumar A; Udayakumaran S; Babu R; Rajamma BM; Prakash A; Panikar D; Karim S; Chowdhary A
Mycoses; 2015 Feb; 58(2):99-103. PubMed ID: 25590228
[TBL] [Abstract][Full Text] [Related]
37. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.
Ruan SY; Chien JY; Hsueh PR
Clin Infect Dis; 2009 Jul; 49(1):e11-7. PubMed ID: 19489711
[TBL] [Abstract][Full Text] [Related]
38. Subcutaneous Infection Associated with Trichosporon ovoides: A Case Report and Review of Literature.
Mohd Tap R; Sabaratnam P; Ramli NY; Hashim R; Mohd Fuat AR; Ng PP; Khairam H; Ahmad N
Mycopathologia; 2016 Apr; 181(3-4):285-90. PubMed ID: 26493614
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the kidney fungal burden in experimental disseminated candidiasis by species of the Candida parapsilosis complex treated with fluconazole, amphotericin B and caspofungin in a temporarily neutropenic murine model.
Szilágyi J; Földi R; Gesztelyi R; Bayegan S; Kardos G; Juhász B; Majoros L
Chemotherapy; 2012; 58(2):159-64. PubMed ID: 22626860
[TBL] [Abstract][Full Text] [Related]
40. Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov.
Taj-Aldeen SJ; Al-Ansari N; El Shafei S; Meis JF; Curfs-Breuker I; Theelen B; Boekhout T
J Clin Microbiol; 2009 Jun; 47(6):1791-9. PubMed ID: 19321719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]